UBS Group’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,500
Closed -$46.2K 10266
2022
Q4
$46.2K Buy
+1,500
New +$46.6K ﹤0.01% 6843

Other funds holding RTO

UBS Group's RTO Position: Q1 2026 in Review

UBS Group increased its Rentokil (RTO) stake by 261% in Q1 2026, buying an estimated $9.34M and bringing the position to 409,757 shares worth $12.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3079.

UBS Group first reported a position in RTO in Q4 2022 and has held it in 14 quarters since. The position peaked at $14.9M in Q1 2025. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • UBS Group held 409,757 shares of Rentokil worth $12.9M as of Q1 2026.
  • UBS Group bought 296,389 Rentokil shares in Q1 2026, an estimated $9.34M.
  • Rentokil made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3079 holding.
  • UBS Group first reported a position in Rentokil in Q4 2022 and has held it in 14 quarters since.
  • UBS Group's Rentokil position peaked at $14.9M in Q1 2025.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.